奇正藏药(002287) - 2021 Q1 - 季度财报

Financial Performance - The company's operating revenue for Q1 2021 was CNY 325,918,211.50, representing a 113.97% increase compared to CNY 152,316,037.10 in the same period last year[10]. - Net profit attributable to shareholders was CNY 103,434,628.21, up 112.26% from CNY 48,730,150.83 year-on-year[10]. - Basic earnings per share increased by 110.39% to CNY 0.1944 from CNY 0.0924 in the same period last year[10]. - Operating revenue rose by 113.97% to ¥325,918,211.50 as business normalized following effective control of COVID-19[29]. - Net profit attributable to shareholders increased by 112.26% to ¥103,434,628.21, driven by growth in operating revenue[29]. - Total operating income for the current period reached ¥160,323,582.77, a significant increase from ¥90,457,223.84 in the previous period, representing an increase of approximately 77%[92]. - Net profit for the current period was ¥103,218,844.63, compared to ¥48,478,920.29 in the previous period, indicating a growth of about 113%[87]. - The company reported a net profit of CNY 1,300,806,853.71, up from CNY 1,197,371,359.20, indicating an increase of approximately 8.6%[74]. Cash Flow - The net cash flow from operating activities decreased by 59.51%, amounting to CNY 129,100,930.10 compared to CNY 318,812,974.85 in the previous year[10]. - Cash inflow from operating activities totaled CNY 444,418,171.87, down from CNY 561,417,282.03 in the prior period[103]. - Cash outflow from investing activities was CNY 614,692,547.72, compared to CNY 928,127,925.05 in the previous period[103]. - Cash flow from financing activities resulted in a net outflow of CNY -102,370,500.00, compared to a net inflow of CNY 101,221,727.79 in the previous period[105]. - The ending balance of cash and cash equivalents was CNY 1,242,170,976.59, down from CNY 871,672,211.69 year-over-year[105]. Assets and Liabilities - Total assets at the end of the reporting period were CNY 4,407,792,414.64, a decrease of 1.15% from CNY 4,459,100,471.49 at the end of the previous year[10]. - The total liabilities decreased to CNY 2,907,792,414.64 from CNY 2,959,100,471.49, indicating a reduction of about 1.7%[68]. - The company's total assets as of March 31, 2021, were CNY 4,407,792,414.64, down from CNY 4,459,100,471.49, a decrease of approximately 1.2%[68]. - The total current assets as of March 31, 2021, amounted to CNY 2,908,556,605.14, a decrease from CNY 2,970,537,154.89 as of December 31, 2020, reflecting a decline of approximately 2.1%[65]. - The total equity attributable to shareholders increased to CNY 2,545,952,778.43 from CNY 2,477,787,575.87, marking an increase of about 2.8%[81]. Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 32,047[14]. - The largest shareholder, Gansu Qizheng Industrial Group Co., Ltd., held 68.74% of the shares, amounting to 364,546,473 shares[14]. Investments and Expenditures - The company has invested CNY 600,000,000.00 in financial products during the reporting period, with no redemptions recorded[49]. - The company has engaged in entrusted financial management, with a total of CNY 60,000,000.00 in entrusted financial products, all of which are still outstanding[51]. - R&D expenses grew by 112.79% to ¥12,551,750.37, indicating increased investment in research activities[29]. - Sales expenses increased by 154.43% to ¥126,621,076.21, reflecting higher investment in sales activities[29]. Government and Financial Support - The company received government subsidies totaling CNY 759,620.10 during the reporting period[10]. - The fair value changes of financial assets resulted in a gain of CNY 1,883,698.63 during the reporting period[10]. Compliance and Governance - The company has no reported violations regarding external guarantees during the reporting period[59]. - There were no non-operating fund occupations by controlling shareholders or related parties during the reporting period[60]. - The company did not engage in any research, communication, or interview activities during the reporting period[61]. - The first quarter report for 2021 was not audited[124].